Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | -0.24 | 8e-10 |
mRNA | ATP6V1G2 | CTRPv2 | pan-cancer | AAC | -0.24 | 8e-10 |
mRNA | WDR62 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | FANCC | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | C16orf59 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | USP13 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-09 |
mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
mRNA | RAB39B | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |